Neuren Pharmaceuticals Ltd (NURPF)
13.91
+0.35
(+2.58%)
USD |
OTCM |
May 22, 16:00
Neuren Pharmaceuticals Shareholders Equity (Quarterly): 139.81M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 139.81M |
June 30, 2023 | 60.58M |
December 31, 2022 | 28.29M |
June 30, 2022 | 23.04M |
December 31, 2021 | 28.45M |
June 30, 2021 | 12.50M |
December 31, 2020 | 18.61M |
June 30, 2020 | 6.248M |
December 31, 2019 | 9.694M |
June 30, 2019 | 11.75M |
December 31, 2018 | 17.38M |
June 30, 2018 | 12.87M |
December 31, 2017 | 12.76M |
June 30, 2017 | 0.7546M |
December 31, 2016 | 3.026M |
June 30, 2016 | 5.657M |
December 31, 2015 | 10.49M |
June 30, 2015 | 11.77M |
Date | Value |
---|---|
December 31, 2014 | 15.79M |
June 30, 2014 | 20.18M |
December 31, 2013 | 21.90M |
June 30, 2013 | 4.503M |
December 31, 2012 | 6.736M |
June 30, 2012 | 8.753M |
December 31, 2011 | 9.629M |
June 30, 2011 | 5.485M |
December 31, 2010 | 3.630M |
June 30, 2010 | 5.022M |
December 31, 2009 | 6.722M |
June 30, 2009 | 2.879M |
December 31, 2008 | 3.929M |
June 30, 2008 | 11.31M |
June 30, 2007 | 7.794M |
June 30, 2006 | 10.61M |
December 31, 2005 | 14.58M |
June 30, 2005 | 13.88M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
6.248M
Minimum
Jun 2020
139.81M
Maximum
Dec 2023
33.90M
Average
20.82M
Median
Shareholders Equity (Quarterly) Benchmarks
Alterity Therapeutics Ltd | 26.42M |
Kazia Therapeutics Ltd | 3.589M |
Immutep Ltd | 22.88M |
Opthea Ltd | -46.91M |
Mesoblast Ltd | 501.84M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 168.94M |
Total Liabilities (Quarterly) | 29.13M |
Current Ratio | 5.780 |